Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    72
    CASES:
    72
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    9
    Tissue Array Type:
    FFPE
    Species:
    Human
FDA800c
$255.00
Add To Collect

Description: Multiple organ tumor tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FDA800b

Details: Multiple tumor tissue microarray, containing 72 cases of tumor of various organ tissue (skin, lung, testis, prostate, gallbladder, small intestine, pancreas, colon, rectum, esophagus, appendix, oral cavity, stomach, liver, breast, uterus, ovary, mediastinum, thyroid, brain, bladder, kidney, lymph node, soft tissue, body cavity and bone), single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Malignant(G1 IB)
  • Malignant(0)
  • Benign(*)
  • Malignant(G2 IIA)
  • Malignant(G3 IIA)
  • Malignant(G3 IIB)
  • Malignant(G3 III)
  • Malignant(*)
  • Malignant(G3 IIIB)
  • Malignant(G2 IIB)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Malignant(IIIC)
  • Malignant(III)
  • Malignant(IV)
TISSUE ARRAYS
FDA800c
1
2
3
4
5
6
7
8
9
A
Ski
Ski
Lun
Lun
Lun
Lun
Lun
Tes
Tes
B
Tes
Pro
Pro
Gal
Gal
Sma
Sma
Pan
Pan
C
Col
Col
Rec
Rec
Rec
Eso
Eso
App
Ton
D
Par
Sto
Liv
Liv
Bre
Bre
Bre
Bre
Ute
E
Ute
Ute
Ute
Cer
Ova
Ova
Med
Thy
Thy
F
Bra
Bra
Bra
Bra
Cer
Bla
Bla
Kid
Kid
G
Kid
Lym
Lym
Lym
Spl
Lym
Sof
Sof
Ret
H
Ret
Abd
Ret
Abd
Pel
Sof
Pel
Bon
Per
FDA800c
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 55 M Skin Basal cell carcinoma of head * T2N0M0 II Malignant
A2
2 46 M Skin Squamous cell carcinoma of left chest wall 2 T3N0M0 II Malignant
A3
3 75 M Lung Small cell carcinoma * * * Malignant
A4
4 49 F Lung Adenocarcinoma 2--3 T2N1M0 IIB Malignant
A5
5 45 M Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant
A6
6 60 F Lung Sarcomatoid carcinoma * T3N0M0 IIIB Malignant
A7
7 62 F Lung Adenocarcinoma 2 T2N1M0 IIB Malignant
A8
8 32 M Testis spermatocytoma * T1N0M0 IA Malignant
A9
9 50 M Testis spermatocytoma * T1N0M0 IA Malignant
B1
10 25 M Testis Embryonal carcinoma * T4N1M0 IIA Malignant
B2
11 66 M Prostate Adenocarcinoma (Gleason grade:5; Gleason score:5+4) 3 T3aN0M0 III Malignant
B3
12 64 M Prostate Pleomorphic rhabdomyosarcoma * T2bN0M0 G3 IIIB Malignant
B4
13 64 F Gallbladder Adenocarcinoma 2 T2N1M0 III Malignant
B5
14 76 M Gallbladder Adenosquamous carcinoma * T3N0M0 IIIA Malignant
B6
15 35 F Small intestine Adenocarcinoma 2 T4N0M0 II Malignant
B7
16 71 F Small intestine Malignant interstitialoma * T2N0M0 G2 IIB Malignant
B8
17 64 M Pancreas Duct adenocarcinoma 2--3 T3N0M0 IIA Malignant
B9
18 51 F Pancreas Islet cell carcinoma * * * Malignant
C1
19 67 M Colon Adenocarcinoma 3 T3N0M0 IIA Malignant
C2
20 54 M Colon Malignant interstitialoma * T2N0M0 G2 IIB Malignant
C3
21 60 M Rectum Adenocarcinoma 3 T3N1M0 II Malignant
C4
22 48 M Rectum Low grade malignant interstitialoma * T2N0M0 G1 IB Malignant
C5
23 54 F Rectum Malignant melanoma * T3N2M0 III Malignant
C6
24 61 M Esophagus Squamous cell carcinoma 2 T2N0M0 IIA Malignant
C7
25 68 M Esophagus Adenocarcinoma 3 T3N1M0 IIIA Malignant
C8
26 50 F Appendix Adenocarcinoma 2 T1N0M0 I Malignant
C9
27 78 M Tongue Squamous cell carcinoma 3 T2N0M0 II Malignant
D1
28 72 F Parotid gland Adenoid cystic carcinoma * T2N0M0 II Malignant
D2
29 57 M Stomach Mucinous adenocarcinoma 2--3 T4N1M0 IV Malignant
D3
30 17 F Liver Embryonic hepatoblastoma * * * Malignant
D4
31 56 M Liver Hepatocellular carcinoma 3 T3N0M0 III Malignant
D5
32 44 F Breast Ductal carcinoma in situ * TisN0M0 0 Malignant
D6
33 45 F Breast Carcinoma in situ * T2N1M0 IIB Malignant
D7
34 38 F Breast Ductal carcinoma in situ * TisN0M0 0 Malignant
D8
35 47 F Breast Medullary carcinoma * T2N2M0 IIIA Malignant
D9
36 48 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E1
37 39 F Uterus Clear cell carcinoma * T2bN0M0 IIB Malignant
E2
38 50 F Uterus Leiomyoma * * * Benign
E3
39 60 F Uterus Squamous cell carcinoma 3 T2N0M0 II Malignant
E4
40 44 F Cervix Endocervical type adenocarcinoma 1 T1b1N0M0 IB Malignant
E5
41 29 F Ovary Mucinous papillary carcinoma 2--3 T3N0M0 III Malignant
E6
42 50 F Ovary High grade serous carcinoma * T3cN0M0 IIIC Malignant
E7
43 61 M Mediastinum Thymoma (type B3) * T1N0M0 I Malignant
E8
44 33 F Thyroid Medullary carcinoma * T3N0M0 II Malignant
E9
45 45 F Thyroid Papillary carcinoma * T2N1M0 III Malignant
F1
46 65 F Brain Atypical meningioma * * * Malignant
F2
47 15 F Brain Malignant ependymoma of right occipital lobe * * * Malignant
F3
48 41 M Brain Anaplastic oligodendroglioma 3 * * Malignant
F4
49 59 M Brain Glioblastoma 4 * * Malignant
F5
50 27 F Cerebellum Medulloblastoma * * * Malignant
F6
51 65 M Bladder High grade urothelial carcinoma with phosphatization * T3N0M0 III Malignant
F7
52 62 M Bladder Leiomyosarcoma * T2bN0M0 G1 IB Malignant
F8
53 66 M Kidney High grade urothelial carcinoma * T1N0M0 I Malignant
F9
54 57 F Kidney Papillary renal cell carcinoma * T2N0M0 II Malignant
G1
55 63 F Kidney Clear cell carcinoma * * * Malignant
G2
56 53 F Lymph node Diffuse B-cell lymphoma of neck * * * Malignant
G3
57 50 F Lymph node Diffuse B-cell lymphoma of right thigh * * * Malignant
G4
58 37 M Lymph node Diffuse B-cell lymphoma of left groin * * * Malignant
G5
59 21 M Spleen Diffuse B-cell lymphoma * * * Malignant
G6
60 40 M Lymph node Hodgkin’s lymphoma of left neck * * * Malignant
G7
61 78 M Soft tissue Moderate malignant leiomyosarcoma of chest wall * T1aN0M0 G2 IIA Malignant
G8
62 20 F Soft tissue Embryonal rhabdomyosarcoma of left leg * T1aN0M0 G3 IIA Malignant
G9
63 48 F Retroperitoneum Pleomorphic rhabdomyosarcoma * T2N0M0 G3 IIB Malignant
H1
64 14 F Retroperitoneum Primitive neuroectodermal tumor * T2N0M0 IIIB Malignant
H2
65 44 M Abdominal wall Clear cell sarcoma * T2N0M0 G3 IIIB Malignant
H3
66 18 M Retroperitoneum Neuroblastoma * * * Malignant
H4
67 48 F Abdominal cavity Mucinous liposarcoma * T2bN0M0 G3 III Malignant
H5
68 56 M Pelvic cavity Chordoma * * * Malignant
H6
69 21 M Soft tissue Neurofibroma of back * * * Malignant
H7
70 40 M Pelvic cavity Synovial sarcoma of right chest wall * T2bN0M0 IIB Malignant
H8
71 7 F Bone Osteosarcoma of right femur * T2N0M0 G3 IIB Malignant
H9
72 33 M Peritoneum Epithelial malignant mesothelioma * * * Malignant
Find overlapping cases with this tissue array:
  • FDA800c
    File Format: .xlsx
    Release Date: 2025-01-21 14:30:16
    Download
2.284896s